Vycor Medical (VYCO) Cash from Discontinued Operations (2019 - 2026)
Vycor Medical (VYCO) posted quarterly Cash from Discontinued Operations of 1117.0 for Q1 2026, up 2179.59% year-over-year from 49.0 in Q1 2025, and up 262.66% quarter-over-quarter from 308.0 in Q4 2025.
Vycor Medical (VYCO) Cash from Discontinued Operations (2019 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Cash from Discontinued Operations for 8 consecutive years, with 1117.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Discontinued Operations rose 2179.59% year-over-year to 1117.0; the TTM figure through Mar 2026 stood at 1704.0 (up 764.97% YoY), while the FY2025 annual figure was 636.0, up 154.4% from the prior year.
- Cash from Discontinued Operations rose to 1117.0 in Q1 2026 per VYCO's latest filing, from 308.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 1117.0 in Q1 2026 and bottomed at 1116.0 in Q2 2022.
- Historically, Cash from Discontinued Operations has averaged 65.65 across 5 years, with a median of 53.0 in 2024.
- Annual changes were most pronounced in 2023 — Cash from Discontinued Operations plunged 287.82% — and 2026, when it jumped 2179.59%.
- Vycor Medical's Cash from Discontinued Operations stood at 322.0 in 2022, then surged by 55.59% to 143.0 in 2023, then soared by 137.06% to 53.0 in 2024, then jumped by 481.13% to 308.0 in 2025, then soared by 262.66% to 1117.0 in 2026.
- Business Quant data shows VYCO's Cash from Discontinued Operations at 1117.0 in Q1 2026, 308.0 in Q4 2025, and 53.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 53.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,117.00 |
| Mar 31, 2026 | 1,117.00 |
| Dec 31, 2025 | 308.00 |
| Dec 31, 2025 | 308.00 |
| Sep 30, 2025 | 53.00 |
| Sep 30, 2025 | 53.00 |
| Jun 30, 2025 | 226.00 |
| Jun 30, 2025 | 226.00 |
| Mar 31, 2025 | 49.00 |
| Mar 31, 2025 | 49.00 |
| Dec 31, 2024 | 53.00 |
| Dec 31, 2024 | 53.00 |
| Sep 30, 2024 | 47.00 |
| Sep 30, 2024 | 47.00 |
| Jun 30, 2024 | 48.00 |
| Jun 30, 2024 | 48.00 |
| Mar 31, 2024 | 102.00 |
| Mar 31, 2024 | 102.00 |
| Dec 31, 2023 | -143.00 |
| Dec 31, 2023 | -143.00 |